Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Melanoma 3Carcinoma, Squamous Cell 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pleural Effusion, Malignant 1Neoplasm Metastasis 1Mycosis Fungoides 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Hemangiosarcoma 1Head and Neck Neoplasms 1Carcinoma, Merkel Cell 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 11Cetuximab 10Radiotherapy 7Fluorouracil 6Docetaxel 5pembrolizumab 4Carboplatin 4figitumumab 3Radiation 3Paclitaxel 3Erlotinib Hydrochloride 3Bleomycin 3130-nm albumin-bound paclitaxel 3talimogene laherparepvec 2avelumab 2Surgical Procedures, Operative 2Oxaliplatin 2Lapatinib 2Capecitabine 2zalutumumab 1yeast-CEA vaccine 1temsirolimus 1temoporfin 1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1selinexor 1remetinostat 1ponatinib 1patritumab 1nilotinib 1necitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Squamous Cell × talimogene laherparepvec × Clear all
NCT02890368 2023-04-05

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Pfizer

Phase 1 Terminated
56 enrolled
BreastDermatologicLymphoidSarcoma

Breast Neoplasms, Carcinoma, Squamous Cell, Melanoma, Mycosis Fungoides, Sarcoma, Carcinoma, Merkel Cell

NCT01161498 2016-02-08

Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer

BioVex Limited

Phase 3 Terminated
5 enrolled 8 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡